Takeda Gets Serious About Cell Therapy With TiGenix Buy

Takeda will acquire its Belgian biotech partner, TiGenix, to strengthen its gastro-intestinal portfolio, bolster its regenerative medicines capacity and grow its US specialty care presence.

Crocodile
Takeda snaps up TiGenix for sole rights to IBD cell therapy • Source: Shutterstock

More from Deals

More from Business